We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Janssen Biotech Licenses Alligator Bioscience's Lead Cancer Immunotherapy

News   Aug 13, 2015

 
Janssen Biotech Licenses Alligator Bioscience's Lead Cancer Immunotherapy
 
 
 

RELATED ARTICLES

HIV Suppressed for up to Four Months by Novel Antibody

News

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months.

READ MORE

Guarding Against Cancer

News

Researchers from the University of Dundee have shown that a drug previously used to treat Type II diabetes could potentially be used to protect against cancer.

READ MORE

Cervical Cancer More Aggressive When HPV Is Not Detected

News

Cervical cancer negative for the human papilloma virus is rare but more aggressive: it is more frequently diagnosed at advanced stages, with more metastasis and reduced survival.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE